Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
about
Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chemotherapy with gemcitabine, ...... ncology Research Group (HORG).
@ast
Chemotherapy with gemcitabine, ...... ncology Research Group (HORG).
@en
type
label
Chemotherapy with gemcitabine, ...... ncology Research Group (HORG).
@ast
Chemotherapy with gemcitabine, ...... ncology Research Group (HORG).
@en
prefLabel
Chemotherapy with gemcitabine, ...... ncology Research Group (HORG).
@ast
Chemotherapy with gemcitabine, ...... ncology Research Group (HORG).
@en
P2093
P2860
P1476
Chemotherapy with gemcitabine, ...... ncology Research Group (HORG).
@en
P2093
Aris Polyzos
Athanasios Karampeazis
Athanasios Kostakopoulos
Athanasios Kotsakis
Constantine A Constantinides
Dimitris Mavroudis
George Samonis
Ioannis Boukovinas
Nikolaos Androulakis
Nikolaos Kentepozidis
P2860
P2888
P304
P356
10.1007/S00280-011-1694-9
P577
2011-07-12T00:00:00Z
P6179
1004538889